🇺🇸 FDA
Patent

US 8642788

Activators of executioner procaspases 3, 6 and 7

granted A61PA61P35/00A61P43/00

Quick answer

US patent 8642788 (Activators of executioner procaspases 3, 6 and 7) held by The Regents of the University of California expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P35/00, A61P43/00